MetaADEDB 2.0 @ LMMD
Carcinoma in Situ
(UMLS:C0007099)
Definition:
A lesion with cytological characteristics associated with invasive carcinoma but the tumor cells are confined to the epithelium of origin, without invasion of the basement membrane.
UMLS ID:
C0007099
MeSH ID:
D002278
Classification:
Name:
Neoplasms
MeSH Tree Number(s):
C04.557.470.200.240
Synonym(s)
1.
Carcinoma in Situ
2.
CARCINOMA IN SITU
3.
CARCINOMA, IN SITU, MALIGNANT
4.
CIS
5.
CIS - Carcinoma in situ
6.
Cancer in situ
7.
Carcinoma In Situ
8.
Carcinoma in situ
9.
Carcinoma in situ - category
10.
Carcinoma in situ NOS
11.
Carcinoma in situ morphology
12.
Carcinoma in situ tumor
13.
Carcinoma in situ tumour
14.
Carcinoma in situ, NOS
15.
Carcinoma in situ, no ICD-O subtype
16.
Carcinoma in situ, no International Classification of Diseases for Oncology subtype
17.
Carcinoma in situ, site unspecified
18.
Carcinoma in situ, unspecified
Associated Drug(s)
NameNumber of ReportsReference(s)Data Source
1NorgestrelFAERS: 7US FAERS
2Fingolimod HydrochlorideFAERS: 5US FAERS
3Medroxyprogesterone AcetateFAERS: 3US FAERS
4TacrolimusFAERS: 3US FAERS
5NuvaRingFAERS: 2US FAERS
6TeriparatideFAERS: 2US FAERS
7DasatinibFAERS: 1US FAERS
8KetamineFAERS: 1US FAERS
9OmeprazoleFAERS: 1US FAERS
10VemurafenibFAERS: 1US FAERS
11Zoledronic AcidFAERS: 1US FAERS
122-amino-1-methyl-6-phenylimidazo(4,5-b)pyridine12507937CTD
13Benzo(a)pyrene25908611CTD
14SunitinibCanada Vigilance: 1Canada Vigilance
15bisphenol A17123778CTD
16dibenzo(a,l)pyrene25908611CTD
Similar ADE(s)
NameSemantic Similarity
1Adenocarcinoma48.4%
2Carcinoma, Transitional Cell48.4%
3Carcinoma, Large Cell48.4%
4Carcinoma, Small Cell48.4%
5Basal cell carcinoma47.3%
6Carcinoma, Papillary47.3%
7Squamous cell carcinoma47.3%
8Carcinoma, Basal Cell47.3%
9Cystadenocarcinoma39%
10Mucoepidermoid Carcinoma39%
11Carcinoma, Ehrlich Tumor38.9%
12Carcinoma, Lewis Lung38.9%
13Adenoid Cystic Carcinoma36%
14Adenocarcinoma, Clear Cell36%
15Cholangiocarcinoma36%
16Bowen's Disease35.1%
17Adenoma34.4%
18Cystadenoma30.1%
19Mesothelioma30.1%
20Klatskin Tumor29.9%
21Neoplasms, Neuroepithelial26.8%
22Gliomatosis cerebri26.8%
23Carcinoma, Lobular25.6%
24leukemia25.4%
25Neoplasms, Germ Cell and Embryonal25.4%
26Germ Cell Cancer25.4%
27Carcinoid Tumor25.1%
28Papilloma22.6%
29Pseudomyxoma Peritonei22.6%
30Papillomatosis22.6%
31Adenomatosis, Pulmonary22.6%
32Adenomatous Polyps22.6%
33Malignant Carcinoid Syndrome20.8%
34Choriocarcinoma20.4%
35Neuroectodermal Tumors19.8%
36Adenofibroma18.9%
37Fibroadenoma18.9%
38Acanthoma18.5%
39Adenoma, Acidophil18.4%
40Ganglioneuroma18.4%
41Glioma18.4%
42Malignant Glioma18.4%
43Histiocytic Disorders, Malignant16.9%
44Hamartoma16.4%
45Neoplasms, Hormone-Dependent16.4%
46Neoplasms, Multiple Primary16.4%
47Paraneoplastic Syndromes16.4%
48Precancerous Conditions16.4%
49Neoplasms, Second Primary16.4%
50Carcinosarcoma16.3%
51Hemangiosarcoma16.3%
52lymphangiosarcoma16.3%
53Medulloblastoma16.3%
54Carcinoid Heart Disease15.3%
55Ameloblastoma14.8%
56Angiokeratoma14.8%
57Chordoma14.8%
58Hemangioma14.8%
59hemangiopericytoma14.8%
60Lymphangioma14.8%
61Mesenchymoma14.8%
62Nevus14.8%
63Teratoma14.8%
64Hepatoblastoma14.8%
65Mixed Tumor, Mullerian14.8%
66Germinoma14.8%
67Teratocarcinoma14.8%
68Angiofibroma14.8%
69Sarcoma14.8%
70Carcinoma, Ovarian Epithelial14.7%
71melanoma14.5%
72Astrocytoma14.3%
73Ependymoma14.3%
74oligodendroglioma14.3%
75Ganglioglioma14.3%
76gliosarcoma14.3%
77Anaplastic astrocytoma14.3%
78Anaplastic Oligodendroglioma14.3%
79Carcinoma, Pancreatic Ductal13.5%
80Basal Cell Nevus Syndrome12.9%
81Chondrosarcoma12.9%
82Craniopharyngioma12.9%
83leiomyosarcoma12.9%
84liposarcoma12.9%
85synovial sarcoma12.9%
86Neuroectodermal Tumor, Melanotic12.9%
87Angiomyolipoma12.9%
88Clear Cell Sarcoma of Soft Tissue12.9%
89Alveolar Soft Part Sarcoma12.9%
90Neuroendocrine Tumors12.9%
91Sarcoma, Myeloid12.9%
92Adrenocortical carcinoma12.8%
93Carcinoma 256, Walker12.8%
94Meningioma12.7%
95Lymphoma12.6%
96Nasopharyngeal carcinoma12.6%
97Glioblastoma12.3%
98Neuroblastoma12.3%
99Glioblastoma Multiforme12.3%
100Dermoid Cyst12.2%
101Leukemia, Plasma Cell12.2%
102Trophoblastic Neoplasms11.8%
103Composite Lymphoma11.8%
104Leukemia, Experimental11.7%
105Ganglioneuroblastoma11.2%
106Fibrosarcoma11.2%
107Osteosarcoma11.2%
108Renal Cell Carcinoma11%
109Papillary Renal Cell Carcinoma11%
110Cyst10.8%
111Neoplastic Processes10.8%
112Neoplastic Syndromes, Hereditary10.8%
113Pregnancy Complications, Neoplastic10.8%
114Carcinoma, Endometrioid10.8%
115Neurilemmoma10.8%
116Hutchinson's Melanotic Freckle10.8%
117Melanoma, Amelanotic10.8%
118Neoplasms, Experimental10.6%
119Hepatocellular Adenoma10.5%
120Malignant Fibrous Histiocytoma10.4%
121Retinoblastoma10.2%
122Vipoma10.2%
123Melanoma, Experimental10%
124Gastrinoma9.9%
125Glucagonoma9.9%
126Plasmacytoma9.9%
127Malignant histiocytosis9.8%
128Leukemia L12109.8%
129Leukemia P3889.8%
130Histiocytic sarcoma9.8%
131Phyllodes Tumor9.7%
132Dysgerminoma9.7%
133Hemangioendothelioma9.7%
134Lipoma9.7%
135Myoma9.7%
136Myxoma9.7%
137Neuroma9.7%
138Seminoma9.7%
139Angiolipoma9.7%
140Myelolipoma9.7%
141Neoplasms, Bone Tissue9.7%
142Neoplasms, Fibrous Tissue9.7%
143Smooth Muscle Tumor9.7%
144Desmoplastic Small Round Cell Tumor9.7%
145Chondroma9.7%
146Enchondroma9.7%
147Paraganglioma9.6%
148Rhabdomyosarcoma9.6%
149Giant Cell Tumor of Bone9.6%
150Leukemia, Radiation-Induced9.5%
151Sarcoma, Experimental9.1%
152Thymoma9%
153Dermatofibrosarcoma8.8%
154Dermatofibrosarcoma Protuberans8.8%
155Prolactinoma8.7%
156Growth Hormone-Secreting Pituitary Adenoma8.7%
157Endometrial Stromal Sarcoma8.6%
158Abdominal Neoplasms8.5%
159Erythroplasia8.5%
160Follicular cyst8.5%
161Head and Neck Neoplasms8.5%
162Mucocele8.5%
163Pilonidal Cyst8.5%
164Soft Tissue Neoplasms8.5%
165Thoracic Neoplasms8.5%
166Thyroglossal Cyst8.5%
167Synovial Cyst8.5%
168Aberrant Crypt Foci8.5%
169Sarcoma 1808.1%
170Pheochromocytoma7.9%
171Alveolar rhabdomyosarcoma7.9%
172Neoplasms, Radiation-Induced7.9%
173Lymphangioleiomyomatosis7.7%
174Multiple Endocrine Neoplasia7.4%
175Hodgkin Disease7.3%
176Lymphoma, Non-Hodgkin7.3%
177fibroma7.2%
178Fibromatosis7.2%
179Osteoblastoma7.2%
180Osteoma7.2%
181Rhabdomyoma7.2%
182Chondromatosis7.2%
183Hemangioblastoma7.2%
184Lymphoma, Extranodal NK-T-Cell7.2%
185Paraneoplastic Encephalomyelitis6.8%
186Neurofibrosarcoma6.7%
187Mammary Neoplasms, Experimental6.7%
188Leukemia, Myelomonocytic, Chronic6.5%
189Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative6.5%
190insulinoma6.2%
191Lymphomatoid Granulomatosis6.2%
192Optic Nerve Glioma6%
193Digestive System Neoplasms6%
194Endocrine Gland Neoplasms6%
195Eye Neoplasms6%
196Nervous System Neoplasms6%
197Fibromatosis, Aggressive6%
198Fibromatosis, Abdominal6%
199Primary amyloidosis5.9%
200Bone neoplasms5.7%
201Leukoplakia5.7%
202Lymphocele5.7%
203Pancreatic Cyst5.7%
204Skin Neoplasms5.7%
205Hematologic Neoplasms5.7%
206Nephroblastoma5.6%
207Barrett Esophagus5.6%
208Breast Cyst5.6%
209Actinic keratosis5.6%
210Mediastinal Cyst5.6%
211Neoplasm Invasiveness5.6%
212Neoplasm Metastasis5.6%
213Neoplasm Recurrence, Local5.6%
214Parovarian Cyst5.6%
215Pericardial Cyst5.6%
216Splenic Neoplasms5.6%
217Thymic Cyst5.6%
218Carcinogenesis5.6%
219Myxoid cyst5.6%
220Metastasis5.6%
221Adenomatous Polyposis Coli5.4%
222Hydatidiform Mole5.2%
223Tuberous Sclerosis5.1%
224Mastocytosis5%
225Sturge-Weber Syndrome5%
226Retroperitoneal Neoplasms4.9%
227Gastrointestinal Stromal Tumors4.9%
228Hemangioma, Cavernous4.9%
229Mastocytoma4.9%
230Leukemia, T-Cell4.8%
231Leukemia, B-Cell4.8%
232Mesoblastic Nephroma4.8%
233neurofibroma4.8%
234Mastocytosis, Systemic4.8%
235Lymphoma, Follicular4.8%
236T-Cell Lymphoma4.8%
237Mantle cell lymphoma4.8%
238Acoustic Neuroma4.8%
239Leukemia, Myeloid, Chronic-Phase4.8%
240Multiple Endocrine Neoplasia Type 14.4%
241Waldenstrom Macroglobulinemia4.2%
242Multiple Myeloma4.2%
243Corpus Luteum Cyst4.1%
244Ovarian Cysts4.1%
245Parathyroid Neoplasms4.1%
246Peritoneal Neoplasms4.1%
247Thyroid Neoplasm4.1%
248Thyroid carcinoma4.1%
249Liver Neoplasms, Experimental3.9%
250granulosa cell tumor3.7%
251Precursor B-Cell Lymphoblastic Leukemia-Lymphoma3.6%
252Leukemia, Large Granular Lymphocytic3.6%
253Precursor T-Cell Lymphoblastic Leukemia-Lymphoma3.6%
254Lymphoma, T-Cell, Cutaneous3.6%
255Lymphoma, AIDS-Related3.6%
256Enteropathy-Associated T-Cell Lymphoma3.6%
257Primary Effusion Lymphoma3.6%
258Pancreatic Neoplasm3.4%
259Choledochal Cyst3.4%
260Tracheal Neoplasms3.4%
261Mouth Neoplasms3.4%
262Central Nervous System Neoplasms3.4%
263Vascular Neoplasms3.4%
264Thymus Neoplasms3.4%
265Genital Neoplasms, Female3.3%
266Pancreatic Pseudocyst3.3%
267Peutz-Jeghers Syndrome3.3%
268Leukoplakia, Oral3.3%
269Paraneoplastic Cerebellar Degeneration3.3%
270Lymphatic Metastasis3.3%
271Neoplasms, Unknown Primary3.3%
272Leukemic Infiltration3.3%
273Breast Neoplasms, Male3.3%
274Neoplasm Micrometastasis3.3%
275Triple Negative Breast Neoplasms3.3%
276Dupuytren Contracture3.1%
277Urticaria Pigmentosa3%
278Mycosis Fungoides3%
279Lymphomatoid Papulosis3%
280Plasmablastic lymphoma3%
281Leydig Cell Tumor2.9%
282Esophageal Neoplasms2.7%
283Limbic Encephalitis2.7%
284Thyroid Nodule2.6%
285Adrenal Gland Neoplasms2.6%
286Gastrointestinal Neoplasms2.6%
287Genital Neoplasms, Male2.6%
288Liver neoplasms2.6%
289Uveal Neoplasms2.6%
290Denys-Drash Syndrome2.5%
291Urologic Neoplasms2.5%
292Sebaceous Gland Neoplasms2.5%
293Spinal Neoplasms2.5%
294Bone Marrow Neoplasms2.5%
295Polycystic Ovary Syndrome2.4%
296Burkitt Lymphoma2.4%
297Lambert-Eaton Myasthenic Syndrome2.4%
298Testicular Neoplasms2.4%
299Meningeal Neoplasms2.2%
300Opsoclonus-Myoclonus Syndrome2.1%
301Sezary Syndrome2%
302Xeroderma Pigmentosum1.9%
303Myelitis, Transverse1.8%
304Ear Neoplasms1.7%
305Eyelid Neoplasms1.7%
306Lung Neoplasms1.7%
307Nose Neoplasms1.7%
308Pleural Neoplasms1.7%
309ovarian neoplasm1.7%
310Cell Transformation, Viral1.6%
311Brain Neoplasms1.6%
312Salivary Gland Neoplasms1.6%
313Spinal Cord Neoplasms1.6%
314Tongue Neoplasms1.6%
315Palatal Neoplasms1.6%
316Uterine Neoplasms1.6%
317Vaginal Neoplasms1.6%
318Vulvar Neoplasms1.6%
319Uterine Cancer1.6%
320Fallopian Tube Neoplasms1.6%
321Meningeal Carcinomatosis1.6%
322Pituitary Adenoma1.5%
323Pituitary Neoplasms1.5%
324Pharyngeal Neoplasms1.4%
325Central Nervous System Cysts1.3%
326Bile Duct Neoplasms1.3%
327gallbladder neoplasm1.3%
328Intestinal Neoplasms1.3%
329Penile Neoplasms1.3%
330Prostatic Neoplasms1.3%
331Stomach Neoplasms1.3%
332Polycythemia Vera1.3%
333Bronchial Neoplasms1.2%
334Zollinger-Ellison syndrome1.2%
335Multiple Pulmonary Nodules1.2%
336Supratentorial Neoplasms1.2%
337Endometrial Neoplasms1.2%
338Laryngeal neoplasm1.1%
339Bladder Neoplasm1.1%
340Kidney Neoplasm1.1%
341Ureteral Neoplasms1.1%
342Urethral Neoplasms1.1%
343Brain Stem Neoplasms1%
344Hypopharyngeal Neoplasms1%
345Pleural Effusion, Malignant1%
346Hypopharyngeal Cancer1%
347Parotid Neoplasms1%
348Prostatic Neoplasms, Castration-Resistant1%
349Nelson Syndrome1%
350Choroid Plexus Papilloma0.9%
351Cecal Neoplasms0.8%
352Duodenal Neoplasms0.8%
353Tonsillar Neoplasms0.8%
354Cerebellar Neoplasms0.8%
355Nasopharyngeal Neoplasms0.7%
356Colorectal Neoplasms0.7%
357Radicular Cyst0.7%
358Appendiceal Neoplasms0.7%
359Colonic Neoplasms0.7%
360Rectal Neoplasms0.7%
361Paranasal Sinus Neoplasms0.6%
362Anus Neoplasms0.5%
363Sigmoid Neoplasms0.5%
364Maxillary Sinus Neoplasms0.5%
Powered by :

Page last updated at 2020-05-25 10:01:57 (Asia/Shanghai) | You are visitor No. 120234

Copyright © 2019-2020 Laboratory of Molecular Modeling and Design, Shanghai Key Laboratory of New Drug Design, School of Pharmacy, East China University of Science and Technology. All rights reserved.